Moleculin Biotech

MBRX

Börsenwert 8,22 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Vanguard Group Malvern, Pennsylvania	1,07 Mio. $	–	–	–
2	2 Geode Capital Management Boston, Massachusetts	202.000 $	–	–	–
3	3 Whitegate Investment Counselors Concord, New Hampshire	155.000 $	–	–	–
4	4 Truist Financial Charlotte, North Carolina	144.000 $	–	–	–
5	5 CIBC World Market Toronto, Ontario, Canada	143.000 $	–	–	–
6	6 BlackRock New York	83.000 $	–	–	–
7	7 Bank of America Charlotte, North Carolina	40.000 $	–	–	–
8	8 Northern Trust Chicago, Illinois	37.000 $	–	–	–
9	9 Commonwealth Equity Services Waltham, Massachusetts	33.000 $	–	–	–
10	10 Laird Norton Wetherby Wealth Management San Francisco, California	32.000 $	–	–	–
11	11 Dimensional Fund Advisors Austin, Texas	28.000 $	–	–	–
12	12 Morgan Stanley New York	20.000 $	–	–	–
13	13 Raymond James Financial Services Advisors St. Petersburg, Florida	20.000 $	–	–	–
14	14 Citadel Advisors Miami, Florida	18.000 $	–	–	–
15	15 PNC Financial Services Group Pittsburgh, Pennsylvania	13.000 $	–	–	–
16	16 UBS Group Zurich, Switzerland	6.000 $	–	–	–
17	17 Avondale Wealth Management West Lake Hills, Texas	4.000 $	–	–	–
18	18 OneDigital Investment Advisors Overland Park, Kansas	4.000 $	–	–	–
19	APA 19 American Portfolios Advisors Holbrook, New York	2.400 $	–	–	–
20	20 Global Retirement Partners San Rafael, California	2.000 $	–	–	–
21	21 Royal Bank of Canada Toronto, Ontario, Canada	2.000 $	–	–	–
22	22 Centaurus Financial Anaheim, California	–	-13.000 $	–	–
23	23 Two Sigma Securities New York	–	-24.000 $	–	–

Moleculin Biotech MBRX Börsenwert 8,22 Mio. $

Moleculin Biotech

MBRX

Börsenwert 8,22 Mio. $